Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

EVCM

EverCommerce Inc

Feb 09 • 04:00PM ET

10.26

-0.50 -4.65 %

Technology • Software - Infrastructure • USA • NASD

Peers: ADP HUBS SHOP INTU PAYC XYZ PCTY GDDY WIX ZUO

| Held by: IWM VXF IWO SCHA VTWO ONEQ AVSC VTWG IWV SCHB

Index	RUT	P/E	-	EPS (ttm)	-0.00	Insider Own	93.28%	Shs Outstand	180.04M	Perf Week	-14.71%
Market Cap	1.84B	Forward P/E	43.29	EPS next Y	0.24	Insider Trans	-0.41%	Shs Float	12.05M	Perf Month	-15.00%
Enterprise Value	2.27B	PEG	-	EPS next Q	0.05	Inst Own	6.66%	Short Float	8.39%	Perf Quarter	-11.48%
Income	-0.68M	P/S	3.00	EPS this Y	142.75%	Inst Trans	-0.75%	Short Ratio	4.01	Perf Half Y	-5.52%
Sales	612.75M	P/B	2.54	EPS next Y	151.98%	ROA	0.02%	Short Interest	1.01M	Perf YTD	-15.28%
Book/sh	4.05	P/C	17.22	EPS next 5Y	-	ROE	0.04%	52W High	14.41 -28.80%	Perf Year	0.79%
Cash/sh	0.60	P/FCF	15.59	EPS past 3/5Y	23.52% 35.31%	ROIC	-0.05%	52W Low	7.66 33.94%	Perf 3Y	-6.98%
Dividend Est.	-	EV/EBITDA	12.59	Sales past 3/5Y	12.55% 23.61%	Gross Margin	63.92%	Volatility	7.92% 5.19%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.71	EPS Y/Y TTM	99.07%	Oper. Margin	17.70%	ATR (14)	0.64	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.94	Sales Y/Y TTM	-11.61%	Profit Margin	-0.11%	RSI (14)	32.46	Recom	2.33
Dividend Gr. 3/5Y	- -	Current Ratio	1.94	EPS Q/Q	221.73%	SMA20	-13.49%	Beta	1.04	Target Price	12.12
Payout	-	Debt/Eq	0.74	Sales Q/Q	-16.34%	SMA50	-10.54%	Rel Volume	0.50	Prev Close	10.76
Employees	2000	LT Debt/Eq	0.73	Earnings	Nov 06 AMC	SMA200	-5.42%	Avg Volume	252.38K	Price	10.26
IPO	Jul 01, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	308.16% 0.31%	Trades		Volume	132,438	Change	-4.65%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$12
Oct-14-25	Downgrade	Barclays	Overweight → Equal Weight	$11
Mar-15-24	Downgrade	JP Morgan	Neutral → Underweight	$11 → $10
Oct-11-23	Downgrade	JP Morgan	Overweight → Neutral	$14 → $12
Nov-21-22	Downgrade	Piper Sandler	Overweight → Neutral	$11 → $9
Oct-19-22	Initiated	Goldman	Sell	$8
Oct-21-21	Initiated	Barclays	Equal Weight	$21
Jul-26-21	Initiated	RBC Capital Mkts	Outperform	$21
Jul-26-21	Initiated	Raymond James	Outperform	$20
Jul-26-21	Initiated	Piper Sandler	Overweight	$24
Jul-26-21	Initiated	Oppenheimer	Outperform	$24
Jul-26-21	Initiated	JP Morgan	Overweight	$30
Jul-26-21	Initiated	JMP Securities	Mkt Outperform	$22
Jul-26-21	Initiated	Jefferies	Hold	$19
Jul-26-21	Initiated	Goldman	Buy	$21
Jul-26-21	Initiated	Evercore ISI	Outperform	$24
Jul-26-21	Initiated	Deutsche Bank	Buy	$21
Jul-26-21	Initiated	Canaccord Genuity	Buy	$20
Jul-26-21	Initiated	Barclays	Equal Weight	$19

Show Previous Ratings

Jan-28-26 01:00PM	Fastly (FSLY) Surges 5.1%: Is This an Indication of Further Gains? (Zacks)
Jan-19-26 08:01AM	Raymond James Cautions on EverCommerce (EVCM) Growth as Insider Ownership and Liquidity Headwinds Loom (Insider Monkey)
Nov-17-25 08:00AM	EverCommerce to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference (GlobeNewswire)
Nov-14-25 06:48AM	New Strong Buy Stocks for November 14th (Zacks)
Nov-07-25 01:16PM	Why EverCommerce Stock Is Plummeting Today (Motley Fool) -19.33%
12:12AM	Loading…
12:12AM	EverCommerce Inc (EVCM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-06-25 06:35PM	EverCommerce (EVCM) Q3 Earnings Meet Estimates (Zacks)
05:34PM	EverCommerce: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	EverCommerce Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-05-25 07:33AM	EverCommerce Inc (EVCM) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-25 10:00AM	Ignite Visibility Partners with Leading Marketing Technology Services Provider EverConnect to Deepen Lead Generation, Home Services, and Healthcare Capabilities (Business Wire)
09:00AM	EverCommerce Announces Sale of Its Marketing Technologies Solutions to Ignite Visibility (GlobeNewswire)
Oct-21-25 12:00PM	EverCommerce Announces Date of Third Quarter 2025 Earnings Call (GlobeNewswire)
09:17AM	Will Opendoor's Agent Partnerships Strengthen Its Platform Model? (Zacks)
Sep-30-25 09:00AM	Contractors Converge in Las Vegas for Milestone 10th Annual Service World Expo, Featuring High-Impact Speakers and Training to Power the Future of the Trades (GlobeNewswire)
11:01AM	Loading…
Sep-24-25 11:01AM	Can Opendoor's Contribution Margins Withstand Housing Headwinds? (Zacks)
Sep-23-25 12:00PM	EverCommerce (EVCM) Upgraded to Strong Buy: Here's Why (Zacks)
Sep-15-25 04:15PM	EverCommerce Acquires AI Agentic Platform Company ZyraTalk, Expanding and Accelerating AI Capabilities Across SaaS Solutions (GlobeNewswire)
Sep-11-25 08:59AM	OPEN's Profitability Milestone: A Turning Point for the iBuyer Model? (Zacks)
Sep-02-25 09:32AM	OPEN Signals Sequential Revenue Drop in Q3: Can Long-Term Upside Hold? (Zacks)
Aug-29-25 12:20PM	Earnings Estimates Moving Higher for EverCommerce (EVCM): Time to Buy? (Zacks)
Aug-22-25 12:00PM	EverCommerce (EVCM) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Aug-11-25 02:04PM	Evercommerce to Present at Third Quarter Investor Conferences (GlobeNewswire)
Aug-06-25 06:50PM	EverCommerce (EVCM) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +9.83%
05:44PM	EverCommerce: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	EverCommerce Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-05-25 09:46AM	EverCommerce Inc (EVCM) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-30-25 09:00AM	EverCommerce Amends, Reprices and Extends Credit Facility (GlobeNewswire)
Jul-18-25 12:00PM	EverCommerce Announces Date of Second Quarter 2025 Earnings Call (GlobeNewswire)
Jun-23-25 10:30AM	CARET Welcomes Jay Kuhlman as Chief Executive Officer (Business Wire)
09:00AM	Loading…
Jun-19-25 09:00AM	Security Information Systems and Carahsoft Partner to Bring Advanced Alarm Monitoring Solutions to the Public Sector (GlobeNewswire)
May-20-25 09:00AM	EverCommerce Appoints Amy Guggenheim Shenkan to Its Board of Directors (GlobeNewswire)
May-13-25 08:13AM	Affirm Stock Pops Nearly 16% as World Market Joins Its BNPL Network (Zacks)
May-09-25 09:44AM	Q1 2025 EverCommerce Inc Earnings Call (Thomson Reuters StreetEvents) +6.28%
03:50AM	EverCommerce Inc (EVCM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-08-25 06:00PM	EverCommerce (EVCM) Q1 Earnings Miss Estimates (Zacks)
05:03PM	EverCommerce: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	EverCommerce Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 05:15PM	Paycom Software (PAYC) Q1 Earnings and Revenues Top Estimates (Zacks)
10:09AM	What To Expect From EverCommerce Inc (EVCM) Q1 2025 Earnings (GuruFocus.com)
Apr-24-25 04:00PM	EverCommerce Announces Date of First Quarter 2025 Earnings Call (GlobeNewswire)
Apr-22-25 06:38PM	EverCommerce: An Integrated SaaS Platform With An Expanding Market (Seeking Alpha)
Mar-14-25 10:42AM	Q4 2024 EverCommerce Inc Earnings Call (Thomson Reuters StreetEvents)
03:11AM	EverCommerce Inc (EVCM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts (GuruFocus.com)
Mar-13-25 06:00PM	EverCommerce (EVCM) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:35PM	EverCommerce (EVCM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:40PM	EverCommerce: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	EverCommerce Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-11-25 09:00AM	EverCommerce Announces Review of Strategic Alternatives for Marketing Technology Solutions (GlobeNewswire)
Feb-28-25 01:29PM	EverCommerce Presents at the Citizens JMP Tech Conference (GlobeNewswire)
Feb-24-25 04:09PM	EverCommerce Announces Date of Fourth Quarter 2024 Earnings Call (GlobeNewswire)
Jan-09-25 10:00AM	EverCommerce Announces Evan Berlin as the Leader of Its EverHealth Vertical (GlobeNewswire)
Dec-16-24 09:00AM	EverCommerce Successfully Reprices Credit Agreement (GlobeNewswire)
Nov-18-24 01:47PM	Evercommerce to Present at Fourth Quarter Investor Conferences (GlobeNewswire)
09:00AM	New EverCommerce Solution Enhancements Generate Efficiencies for Service-Based SMBs During Small Business November (GlobeNewswire)
Nov-14-24 06:45AM	EverCommerce price target raised to $15 from $12 at JMP Securities (TipRanks)
06:41AM	EverCommerce price target raised to $13 from $12 at Oppenheimer (TipRanks)
Nov-13-24 10:20AM	Q3 2024 EverCommerce Inc Earnings Call (Thomson Reuters StreetEvents) -7.01%
02:24AM	EverCommerce Inc (EVCM) Q3 2024 Earnings Call Highlights: Strong Payments Growth and Strategic ... (GuruFocus.com)
Nov-12-24 06:30PM	Compared to Estimates, EverCommerce (EVCM) Q3 Earnings: A Look at Key Metrics (Zacks)
06:00PM	EverCommerce (EVCM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:03PM	EverCommerce: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	EverCommerce Announces Third Quarter 2024 Financial Results (GlobeNewswire)
04:05PM	EverCommerce Announces Josh McCarter as the Leader of Its EverPro Vertical (GlobeNewswire)
Nov-11-24 07:08AM	Earnings To Watch: EverCommerce Inc (EVCM) Reports Q3 2024 Result (GuruFocus.com)
Oct-21-24 10:56AM	EverCommerce Announces Date of Third Quarter 2024 Earnings Call (GlobeNewswire)
Sep-23-24 09:00AM	TextUs Names Andrew Davis as New Vice President of Marketing (GlobeNewswire)
Sep-20-24 04:15PM	EverCommerce Announces Changes to Its Board Of Directors (GlobeNewswire)
Aug-12-24 02:05PM	Evercommerce to Present at August 2024 Investor Conferences (GlobeNewswire)
Aug-06-24 06:30PM	Compared to Estimates, EverCommerce (EVCM) Q2 Earnings: A Look at Key Metrics (Zacks) -5.29%
06:10PM	EverCommerce (EVCM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:02PM	EverCommerce: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Evercommerce Names Ryan Siurek as Chief Financial Officer (GlobeNewswire)
04:05PM	EverCommerce Announces Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-17-24 03:10PM	EverCommerce Announces Date of Second Quarter 2024 Earnings Call (GlobeNewswire)
May-22-24 07:30AM	EverCommerce Announces an Increase and Extension of its Share Repurchase Program (GlobeNewswire)
May-17-24 11:29AM	EverCommerce to Present at Upcoming Investor Conferences (GlobeNewswire)
May-13-24 11:19AM	EverCommerce Inc. (NASDAQ:EVCM) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 10:13AM	Oppenheimer Adjusts EverCommerce Price Target to $12 From $11, Maintains Outperform Rating (MT Newswires)
09:44AM	Q1 2024 EverCommerce Inc Earnings Call (Thomson Reuters StreetEvents)
03:47AM	EverCommerce's Q1 Net Loss Narrows, Revenue Rises; Issues Q2 Revenue Outlook (MT Newswires)
May-09-24 06:30PM	Compared to Estimates, EverCommerce (EVCM) Q1 Earnings: A Look at Key Metrics (Zacks)
04:56PM	EverCommerce: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	EverCommerce Announces First Quarter 2024 Financial Results (GlobeNewswire)
May-07-24 09:15AM	Stay Ahead of the Game With EverCommerce (EVCM) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Apr-29-24 09:00AM	Three Out of Four Service-Based SMB Owners Are Not Familiar with National Small Business Week, New EverCommerce Survey Finds (GlobeNewswire)
Apr-22-24 02:57PM	EverCommerce Announces Date of First Quarter 2024 Earnings Call (GlobeNewswire)
Apr-21-24 05:30AM	Diversity Goals Are Disappearing From Companies Annual Reports (The Wall Street Journal)
Mar-28-24 04:03PM	EverCommerce Announces New Chief Information Officer and Chief People Officer (GlobeNewswire)
Mar-15-24 10:26AM	EverCommerce Inc. (NASDAQ:EVCM) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.63%
07:01AM	Q4 2023 EverCommerce Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 09:53PM	EVCM Stock Earnings: EverCommerce Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
06:00PM	Compared to Estimates, EverCommerce (EVCM) Q4 Earnings: A Look at Key Metrics (Zacks)
05:51PM	EverCommerce Inc (EVCM) Reports Mixed Q4 Results Amidst Strategic Shifts (GuruFocus.com)
04:51PM	EverCommerce: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	EverCommerce Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-13-24 09:00AM	EverCommerce Announces Divestiture of its Fitness Solutions (GlobeNewswire)
Mar-11-24 09:15AM	Exploring Analyst Estimates for EverCommerce (EVCM) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-29-24 05:44PM	Evercommerce To Present at the Citizens JMP Technology Conference (GlobeNewswire)
05:42PM	EverCommerce Announces Date of Fourth Quarter 2023 Earnings Call (GlobeNewswire)

EverCommerce, Inc. engages in providing integrated, vertically-tailored software-as-a-service solutions for service-based small and medium sized businesses. It operates through the United States and International geographical segments. The company was founded by Eric Remer in September 2016 and is headquartered in Denver, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Feierstein Matthew David	President	Feb 02 '26	Sale	12.06	10,000	120,587	2,055,919	Feb 04 06:14 PM
Feierstein Matthew David	President	Feb 03 '26	Sale	10.99	10,000	109,903	2,045,919	Feb 04 06:14 PM
Feierstein Matthew David	President	Feb 04 '26	Sale	10.80	10,000	107,988	2,035,919	Feb 04 06:14 PM
Remer Eric Richard	Chief Executive Officer	Feb 03 '26	Sale	10.90	16,403	178,872	2,686,815	Feb 04 06:13 PM
Remer Eric Richard	Chief Executive Officer	Feb 04 '26	Sale	10.77	2,797	30,127	2,684,018	Feb 04 06:13 PM
Remer Eric Richard	Officer and Director	Feb 04 '26	Proposed Sale	10.77	2,797	30,127		Feb 04 03:42 PM
Remer Eric Richard	Officer and Director	Feb 03 '26	Proposed Sale	10.90	16,403	178,871		Feb 03 04:47 PM
MATTHEW FEIERSTEIN	Officer	Feb 02 '26	Proposed Sale	12.05	70,000	843,500		Feb 02 04:31 PM
Remer Eric Richard	Chief Executive Officer	Jan 28 '26	Sale	11.95	8,268	98,777	2,706,308	Jan 29 04:46 PM
Remer Eric Richard	Chief Executive Officer	Jan 27 '26	Sale	12.16	7,842	95,395	2,714,576	Jan 29 04:46 PM
Remer Eric Richard	Chief Executive Officer	Jan 29 '26	Sale	11.62	3,090	35,895	2,703,218	Jan 29 04:46 PM
Remer Eric Richard	Officer and Director	Jan 29 '26	Proposed Sale	11.62	3,090	35,895		Jan 29 03:51 PM
Remer Eric Richard	Officer and Director	Jan 28 '26	Proposed Sale	11.95	8,268	98,779		Jan 28 04:41 PM
Remer Eric Richard	Officer and Director	Jan 27 '26	Proposed Sale	12.16	7,842	95,395		Jan 27 04:34 PM
Remer Eric Richard	Chief Executive Officer	Jan 22 '26	Sale	12.70	5,230	66,423	2,722,418	Jan 26 05:55 PM
Remer Eric Richard	Chief Executive Officer	Jan 20 '26	Sale	12.26	7,194	88,188	2,734,424	Jan 22 07:10 PM
Remer Eric Richard	Chief Executive Officer	Jan 21 '26	Sale	12.22	6,776	82,797	2,727,648	Jan 22 07:10 PM
Remer Eric Richard	Officer and Director	Jan 21 '26	Proposed Sale	12.70	5,230	66,421		Jan 22 04:27 PM
Remer Eric Richard	Officer and Director	Jan 21 '26	Proposed Sale	12.22	6,776	82,797		Jan 21 04:19 PM
Remer Eric Richard	Officer and Director	Jan 20 '26	Proposed Sale	12.26	7,194	88,188		Jan 20 04:41 PM
Remer Eric Richard	Chief Executive Officer	Jan 13 '26	Sale	11.82	10,882	128,638	2,749,936	Jan 15 04:49 PM
Remer Eric Richard	Chief Executive Officer	Jan 14 '26	Sale	11.88	8,318	98,805	2,741,618	Jan 15 04:49 PM
Remer Eric Richard	Officer and Director	Jan 14 '26	Proposed Sale	11.88	8,318	98,805		Jan 14 03:18 PM
Remer Eric Richard	Officer and Director	Jan 13 '26	Proposed Sale	11.82	10,882	128,639		Jan 13 04:26 PM
Remer Eric Richard	Chief Executive Officer	Jan 06 '26	Sale	11.52	19,200	221,253	2,760,818	Jan 08 06:47 PM
Feierstein Matthew David	President	Jan 07 '26	Sale	12.10	5,000	60,510	2,065,919	Jan 08 06:43 PM
Feierstein Matthew David	President	Jan 05 '26	Sale	11.66	10,000	116,553	2,080,919	Jan 06 09:02 PM
Feierstein Matthew David	President	Jan 06 '26	Sale	11.62	10,000	116,161	2,070,919	Jan 06 09:02 PM
Feierstein Matthew David	President	Jan 02 '26	Sale	11.37	10,000	113,749	2,090,919	Jan 06 09:02 PM
Remer Eric Richard	Officer and Director	Jan 06 '26	Proposed Sale	11.52	19,200	221,253		Jan 06 04:59 PM
MATTHEW FEIERSTEIN	Officer	Jan 02 '26	Proposed Sale	12.11	35,000	423,850		Jan 02 04:34 PM
Remer Eric Richard	Chief Executive Officer	Dec 30 '25	Sale	12.20	7,303	89,105	2,785,344	Dec 31 06:38 PM
Remer Eric Richard	Chief Executive Officer	Dec 29 '25	Sale	12.11	6,571	79,552	2,792,647	Dec 31 06:38 PM
Remer Eric Richard	Chief Executive Officer	Dec 31 '25	Sale	12.07	5,326	64,271	2,780,018	Dec 31 06:38 PM
Remer Eric Richard	Officer and Director	Dec 31 '25	Proposed Sale	12.13	5,326	64,613		Dec 31 04:14 PM
Remer Eric Richard	Officer and Director	Dec 30 '25	Proposed Sale	12.20	7,303	89,105		Dec 30 04:27 PM
Remer Eric Richard	Chief Executive Officer	Dec 22 '25	Sale	12.06	10,717	129,222	2,799,218	Dec 29 05:01 PM
Remer Eric Richard	Officer and Director	Dec 29 '25	Proposed Sale	12.11	6,571	79,552		Dec 29 04:34 PM
Remer Eric Richard	Officer and Director	Dec 23 '25	Proposed Sale	12.02	8,483	101,944		Dec 23 04:24 PM
Remer Eric Richard	Officer and Director	Dec 22 '25	Proposed Sale	12.06	10,717	129,222		Dec 22 04:33 PM
Siurek Ryan H	Chief Financial Officer	Dec 15 '25	Sale	12.34	8,300	102,446	227,037	Dec 17 05:09 PM
Remer Eric Richard	Chief Executive Officer	Dec 16 '25	Sale	13.61	19,200	261,348	2,809,935	Dec 17 05:08 PM
Storey Lisa E	Chief Legal Officer	Dec 16 '25	Sale	14.28	8,435	120,448	175,730	Dec 17 05:04 PM
LISA STOREY	Officer	Dec 16 '25	Proposed Sale	14.28	8,435	120,448		Dec 16 04:14 PM
Remer Eric Richard	Officer and Director	Dec 16 '25	Proposed Sale	13.61	19,200	261,348		Dec 16 03:16 PM
RYAN SIUREK	Officer	Dec 15 '25	Proposed Sale	12.34	8,300	102,446		Dec 15 04:44 PM
Feierstein Matthew David	President	Dec 10 '25	Sale	10.03	10,921	109,485	2,100,919	Dec 10 08:12 PM
Feierstein Matthew David	President	Dec 09 '25	Sale	10.01	9,779	97,846	2,111,840	Dec 10 08:12 PM
Feierstein Matthew David	President	Dec 08 '25	Sale	10.04	4,300	43,184	2,121,619	Dec 10 08:12 PM
Remer Eric Richard	Chief Executive Officer	Dec 09 '25	Sale	9.87	32,706	322,743	2,833,139	Dec 10 08:11 PM
Remer Eric Richard	Chief Executive Officer	Dec 10 '25	Sale	9.99	4,004	39,983	2,829,135	Dec 10 08:11 PM
Remer Eric Richard	Officer and Director	Dec 10 '25	Proposed Sale	9.99	4,004	39,983		Dec 10 11:32 AM
Remer Eric Richard	Officer and Director	Dec 09 '25	Proposed Sale	9.87	32,706	322,743		Dec 09 04:54 PM
Storey Lisa E	Chief Legal Officer	Dec 05 '25	Sale	9.84	7,651	75,298	185,745	Dec 08 05:18 PM
Remer Eric Richard	Chief Executive Officer	Dec 04 '25	Sale	9.50	26,090	247,790	2,879,617	Dec 08 05:17 PM
LISA STOREY	Officer	Dec 05 '25	Proposed Sale	9.84	7,651	75,298		Dec 05 04:13 PM
Remer Eric Richard	Officer and Director	Dec 04 '25	Proposed Sale	9.50	26,090	247,790		Dec 04 05:28 PM
Remer Eric Richard	Chief Executive Officer	Dec 03 '25	Sale	9.18	28,044	257,335	2,919,229	Dec 04 04:35 PM
Remer Eric Richard	Chief Executive Officer	Dec 02 '25	Sale	9.01	4,056	36,547	2,947,273	Dec 04 04:35 PM
Remer Eric Richard	Officer and Director	Dec 03 '25	Proposed Sale	9.16	14,000	128,173		Dec 03 04:36 PM
Remer Eric Richard	Chief Executive Officer	Nov 11 '25	Sale	9.05	600	5,432	2,972,924	Nov 13 06:58 PM
Remer Eric Richard	Chief Executive Officer	Nov 13 '25	Sale	9.01	500	4,502	2,972,424	Nov 13 06:58 PM
Remer Eric Richard	Officer and Director	Nov 10 '25	Proposed Sale	9.02	19,200	173,184		Nov 10 03:42 PM
Remer Eric Richard	Chief Executive Officer	Nov 04 '25	Sale	11.27	13,534	152,467	2,979,190	Nov 06 04:05 PM
Remer Eric Richard	Chief Executive Officer	Nov 05 '25	Sale	11.37	5,666	64,396	2,973,524	Nov 06 04:05 PM
Feierstein Matthew David	President	Nov 03 '25	Sale	11.38	25,000	284,490	2,148,295	Nov 05 04:06 PM
Remer Eric Richard	Officer and Director	Nov 05 '25	Proposed Sale	11.37	5,666	64,396		Nov 05 03:12 PM
Remer Eric Richard	Officer and Director	Nov 04 '25	Proposed Sale	11.27	13,534	152,467		Nov 04 04:33 PM
Remer Eric Richard	Chief Executive Officer	Oct 29 '25	Sale	11.77	10,643	125,312	2,992,724	Oct 30 04:05 PM
Remer Eric Richard	Chief Executive Officer	Oct 28 '25	Sale	12.08	8,557	103,339	3,003,367	Oct 30 04:05 PM
Remer Eric Richard	Officer and Director	Oct 29 '25	Proposed Sale	11.77	10,643	125,312		Oct 29 04:08 PM
Remer Eric Richard	Officer and Director	Oct 28 '25	Proposed Sale	12.08	8,557	103,338		Oct 28 04:12 PM
Remer Eric Richard	Chief Executive Officer	Oct 21 '25	Sale	11.44	11,735	134,198	3,019,389	Oct 23 09:10 PM
Remer Eric Richard	Chief Executive Officer	Oct 22 '25	Sale	11.42	7,465	85,253	3,011,924	Oct 23 09:10 PM
Remer Eric Richard	Officer and Director	Oct 22 '25	Proposed Sale	11.42	7,465	85,253		Oct 22 03:54 PM
Remer Eric Richard	Officer and Director	Oct 21 '25	Proposed Sale	11.44	11,735	134,198		Oct 21 04:20 PM
Remer Eric Richard	Chief Executive Officer	Oct 14 '25	Sale	10.86	19,200	208,547	3,031,124	Oct 16 04:15 PM
Remer Eric Richard	Officer and Director	Oct 14 '25	Proposed Sale	10.86	19,200	208,547		Oct 14 04:45 PM
Remer Eric Richard	Chief Executive Officer	Oct 07 '25	Sale	11.05	19,200	212,150	3,050,324	Oct 08 08:19 PM
Remer Eric Richard	Officer and Director	Oct 07 '25	Proposed Sale	11.05	19,200	212,150		Oct 07 04:29 PM
Feierstein Matthew David	President	Oct 01 '25	Sale	10.93	25,000	273,340	2,173,295	Oct 03 04:05 PM
Remer Eric Richard	Chief Executive Officer	Sep 30 '25	Sale	11.13	14,664	163,165	3,074,060	Oct 01 05:05 PM
Remer Eric Richard	Chief Executive Officer	Oct 01 '25	Sale	11.02	4,536	49,999	3,069,524	Oct 01 05:05 PM
MATTHEW FEIERSTEIN	Officer	Oct 01 '25	Proposed Sale	11.13	75,000	834,750		Oct 01 04:33 PM
Remer Eric Richard	Officer and Director	Sep 30 '25	Proposed Sale	11.02	4,536	49,999		Oct 01 01:02 PM
Remer Eric Richard	Officer and Director	Sep 30 '25	Proposed Sale	11.13	14,664	163,165		Sep 30 04:28 PM
Remer Eric Richard	Chief Executive Officer	Sep 23 '25	Sale	11.71	18,772	219,745	3,089,152	Sep 24 06:28 PM
Remer Eric Richard	Chief Executive Officer	Sep 24 '25	Sale	11.65	428	4,985	3,088,724	Sep 24 06:28 PM
Remer Eric Richard	Officer and Director	Sep 24 '25	Proposed Sale	11.65	428	4,985		Sep 24 04:16 PM
Remer Eric Richard	Officer and Director	Sep 23 '25	Proposed Sale	11.71	18,772	219,745		Sep 23 04:50 PM
Remer Eric Richard	Chief Executive Officer	Sep 16 '25	Sale	11.85	15,069	178,617	5,133,594	Sep 18 05:53 PM
Remer Eric Richard	Chief Executive Officer	Sep 17 '25	Sale	11.86	4,131	49,011	5,129,463	Sep 18 05:53 PM
Remer Eric Richard	Officer and Director	Sep 17 '25	Proposed Sale	11.86	4,131	49,011		Sep 17 02:28 PM
Remer Eric Richard	Officer and Director	Sep 16 '25	Proposed Sale	11.85	19,200	227,583		Sep 16 04:37 PM
Remer Eric Richard	Chief Executive Officer	Sep 09 '25	Sale	11.56	14,979	173,112	5,153,684	Sep 11 04:05 PM
Remer Eric Richard	Chief Executive Officer	Sep 10 '25	Sale	11.40	5,021	57,221	5,148,663	Sep 11 04:05 PM
Remer Eric Richard	Officer and Director	Sep 10 '25	Proposed Sale	11.40	5,021	57,221		Sep 10 04:46 PM
Remer Eric Richard	Officer and Director	Sep 09 '25	Proposed Sale	11.56	14,979	173,112		Sep 09 04:04 PM
Feierstein Matthew David	President	Sep 02 '25	Sale	11.24	25,000	281,048	2,211,383	Sep 03 06:54 PM
Remer Eric Richard	Chief Executive Officer	Sep 02 '25	Sale	11.23	20,421	229,414	5,172,742	Sep 03 06:53 PM

Open in Screener

BDSX

Biodesix Inc

Feb 09 • 04:00PM ET

9.93

-0.45 -4.34 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN BEAM CDNA FLGT GH EXAS QDEL TWST CRSP PACB

| Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-5.37	Insider Own	60.69%	Shs Outstand	7.95M	Perf Week	-3.50%
Market Cap	79.00M	Forward P/E	-	EPS next Y	-2.43	Insider Trans	380.33%	Shs Float	3.13M	Perf Month	77.96%
Enterprise Value	135.23M	PEG	-	EPS next Q	-0.86	Inst Own	21.75%	Short Float	15.45%	Perf Quarter	27.47%
Income	-39.54M	P/S	0.99	EPS this Y	22.00%	Inst Trans	-3.50%	Short Ratio	0.34	Perf Half Y	23.97%
Sales	80.17M	P/B	-	EPS next Y	52.85%	ROA	-41.30%	Short Interest	0.48M	Perf YTD	46.03%
Book/sh	-0.22	P/C	4.73	EPS next 5Y	41.37%	ROE	-302.55%	52W High	20.60 -51.80%	Perf Year	-52.26%
Cash/sh	2.10	P/FCF	-	EPS past 3/5Y	40.57% 69.26%	ROIC	-56.64%	52W Low	3.44 189.00%	Perf 3Y	-76.91%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.38% 23.77%	Gross Margin	79.82%	Volatility	10.51% 17.97%	Perf 5Y	-97.94%
Dividend TTM	-	EV/Sales	1.69	EPS Y/Y TTM	31.93%	Oper. Margin	-40.35%	ATR (14)	1.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.76	Sales Y/Y TTM	22.29%	Profit Margin	-49.31%	RSI (14)	53.53	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	1.84	EPS Q/Q	17.13%	SMA20	-0.03%	Beta	0.68	Target Price	32.50
Payout	-	Debt/Eq	-	Sales Q/Q	19.93%	SMA50	19.65%	Rel Volume	0.05	Prev Close	10.38
Employees	273	LT Debt/Eq	-	Earnings	Nov 03 AMC	SMA200	30.73%	Avg Volume	1.41M	Price	9.93
IPO	Oct 28, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	22.15% 3.79%	Trades		Volume	76,852	Change	-4.34%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy	$3
May-13-24	Initiated	TD Cowen	Buy	$2.80
May-03-24	Initiated	Lake Street	Buy	$3
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$21 → $11
Nov-23-20	Initiated	William Blair	Outperform
Nov-23-20	Initiated	Morgan Stanley	Overweight	$20
Nov-23-20	Initiated	Canaccord Genuity	Buy	$26
Nov-23-20	Initiated	BTIG Research	Buy	$22

Jan-31-26 08:15AM	Insiders Are Still Scooping Up Under Armour and WR Berkley Shares (24/7 Wall St.)
Jan-12-26 06:00AM	Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited) (GlobeNewswire) +47.99%
Dec-24-25 01:48PM	SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio (Zacks)
Dec-19-25 11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks) -5.77%
Dec-03-25 09:55AM	Wall Street Analysts Believe Biodesix (BDSX) Could Rally 325.67%: Here's is How to Trade (Zacks)
08:22AM	Loading…
08:22AM	Biodesix to Present New Data at Two Major Upcoming Scientific Meetings (GlobeNewswire)
Nov-04-25 12:01AM	Biodesix Inc (BDSX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Costs (GuruFocus.com) +19.87%
Nov-03-25 05:30PM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.17%
04:01PM	Biodesix Announces Third Quarter 2025 Results and Highlights (GlobeNewswire)
Oct-31-25 09:35AM	What To Expect From Biodesix Inc (BDSX) Q3 2025 Earnings (GuruFocus.com)
Oct-30-25 06:17AM	Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting (GlobeNewswire)
Oct-29-25 05:45PM	Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Oct-27-25 07:10AM	Revvity (RVTY) Surpasses Q3 Earnings Estimates (Zacks)
Oct-22-25 06:17AM	Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital PCR High Complexity Assays (GlobeNewswire) -12.15%
Oct-20-25 06:00AM	Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 (GlobeNewswire)
06:09AM	Loading…
Oct-15-25 06:09AM	Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting (GlobeNewswire)
Oct-06-25 10:13AM	Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit (GlobeNewswire)
Sep-11-25 08:00AM	Biodesix Announces One-for-Twenty Reverse Stock Split (GlobeNewswire) -20.82%
Sep-05-25 06:00AM	Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference (GlobeNewswire)
Sep-04-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +5.05%
Aug-19-25 09:47AM	Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics (GlobeNewswire)
Aug-07-25 05:20PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +14.62% -10.40%
04:06PM	Biodesix Announces Second Quarter 2025 Results and Highlights (GlobeNewswire)
Aug-05-25 06:00AM	Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire) +10.10%
Aug-01-25 07:15AM	Avantor, Inc. (AVTR) Q2 Earnings Lag Estimates (Zacks)
Jul-25-25 12:22PM	Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers (Insider Monkey) +6.80%
12:22PM	Sangamo Therapeutics Announces Positive Phase 1/2 STAAR Study Results for Fabry Gene Therapy (Insider Monkey)
Jul-24-25 06:00AM	Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jun-10-25 06:17AM	Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs (GlobeNewswire) +13.91%
May-22-25 05:03PM	Biodesix Announces New Data on the VeriStrat Test to be Presented at the 2025 ASCO Annual Meeting (GlobeNewswire) -9.92%
06:00AM	Loading…
May-21-25 06:00AM	Biodesix to Participate in Upcoming Investor Conferences (GlobeNewswire) +45.90%
May-15-25 06:00AM	Biodesix Announces New Clinical and Economic Data for its Nodify Lung Tests at ISPOR and ATS (GlobeNewswire)
May-14-25 04:01PM	Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award (GlobeNewswire) -38.74%
03:16AM	Biodesix Inc (BDSX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Sales Team ... (GuruFocus.com)
May-13-25 05:15PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2025 Results and Highlights (GlobeNewswire)
May-12-25 09:50AM	Biodesix Inc (BDSX) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
09:25AM	Sonida Senior Living (SNDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-08-25 06:30PM	DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -17.91% +6.84%
Apr-30-25 07:45AM	GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Apr-29-25 06:00AM	Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire) -6.51%
Apr-28-25 07:15AM	Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates (Zacks) +6.25%
Apr-25-25 07:15AM	Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates (Zacks) -5.64%
Apr-23-25 06:00AM	Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types (GlobeNewswire)
Mar-06-25 12:00PM	Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-04-25 05:20AM	Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 (Insider Monkey)
02:03AM	Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Mar-03-25 04:01PM	Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results (GlobeNewswire) -10.09%
Feb-28-25 07:15AM	Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-26-25 06:00AM	Biodesix to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-18-25 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 (GlobeNewswire)
Jan-10-25 06:00AM	Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) (GlobeNewswire) -14.19%
Jan-07-25 06:00AM	Biodesix Announces Publication of a New Nodify CDT Clinical Validation Study (GlobeNewswire)
Nov-20-24 09:35AM	Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-02-24 03:01AM	Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com)
Nov-01-24 07:15AM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -23.53%
06:00AM	Biodesix Announces Third Quarter 2024 Results and Highlights (GlobeNewswire)
Oct-31-24 09:06AM	What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings (GuruFocus.com)
Oct-29-24 06:00AM	Biodesix to Participate in Three Investor Conferences in November (GlobeNewswire)
Oct-18-24 06:00AM	Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 (Business Wire)
Oct-07-24 06:00AM	Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study (Business Wire)
Sep-05-24 06:00AM	Biodesix to Present at Two Investor Conferences in September (Business Wire)
Aug-08-24 10:23AM	Q2 2024 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-24 06:05PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Second Quarter 2024 Results and Highlights (Business Wire)
Aug-06-24 06:00AM	Biodesix to Present at Canaccord Genuitys 44th Annual Growth Conference (Business Wire)
Jul-24-24 06:00AM	Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire)
Jun-18-24 08:13AM	Biodesix Named to Inc. Magazine's 2024 "Best Workplaces" (Business Wire)
May-28-24 06:00AM	Biodesix to Participate in Two Investor Conferences in June (Business Wire)
May-21-24 06:00AM	Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting (Business Wire)
May-10-24 05:59PM	Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:55PM	Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
May-09-24 03:46AM	Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-08-24 09:00PM	BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:20PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management (Business Wire)
May-07-24 06:00AM	Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference (Business Wire)
Apr-24-24 06:00AM	Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 (Business Wire)
Apr-09-24 05:00PM	Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting (Business Wire) -9.93%
Apr-05-24 07:17AM	Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement (Business Wire) -7.28%
Mar-25-24 06:00AM	Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center (Business Wire)
Mar-04-24 09:04AM	Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 10:40PM	Q4 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
06:31AM	Biodesix Inc (BDSX) Reports Strong Growth in Lung Diagnostic Test Volume and Gross Profit Margin (GuruFocus.com)
06:00AM	Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights (Business Wire)
Feb-26-24 06:00AM	Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference (Business Wire)
Feb-16-24 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 (Business Wire) -5.73%
Feb-13-24 03:00AM	Biodesix Inc CEO Scott Hutton Sells 64,390 Shares (GuruFocus.com)
Jan-26-24 09:04AM	3 Penny Stocks to Turn $999 Into $1 Million: January 2024 (InvestorPlace)
Nov-14-23 06:00AM	Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method (Business Wire)
Nov-09-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in November (Business Wire) -6.39%
Nov-07-23 04:01PM	Biodesix Announces Third Quarter 2023 Results and Highlights (Business Wire) -10.14%
Oct-24-23 06:00AM	Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire) -5.00%
Oct-03-23 06:00AM	Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting (Business Wire)
Sep-07-23 06:00AM	Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer (Business Wire)
Sep-05-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in September (Business Wire) -11.76%
Aug-22-23 06:00AM	Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer (Business Wire)
Aug-09-23 10:25AM	Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript (Insider Monkey) -15.62%
Aug-08-23 08:38AM	Q2 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 05:15PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHULER JACK W	Emeritus Director	Jan 23 '26	Buy	11.81	80,000	944,672	1,543,210	Jan 27 09:29 AM
SCHULER JACK W	Emeritus Director	Jan 26 '26	Buy	11.80	20,000	236,064	1,563,210	Jan 27 09:29 AM
SCHULER JACK W	Emeritus Director	Jan 22 '26	Buy	10.96	82,465	903,561	1,463,210	Jan 26 09:28 AM
Vazquez Chris	Chief Accounting Officer	Jan 16 '26	Sale	8.15	83	676	1,072	Jan 20 04:22 PM
Pestano Gary Anthony	Chief Development Officer	Jan 16 '26	Sale	8.15	298	2,428	8,446	Jan 20 04:21 PM
O'Kane Kieran	Chief Commercial Officer	Jan 16 '26	Sale	8.15	298	2,428	7,869	Jan 20 04:21 PM
Hutton Scott	President & CEO	Jan 16 '26	Sale	8.15	970	7,905	38,974	Jan 20 04:21 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Jan 16 '26	Sale	8.15	298	2,428	13,654	Jan 20 04:21 PM
Vazquez Chris	Chief Accounting Officer	Nov 10 '25	Sale	7.62	13	99	936	Nov 13 04:54 PM
Pestano Gary Anthony	Chief Development Officer	Nov 10 '25	Sale	7.62	23	175	7,939	Nov 13 04:54 PM
O'Kane Kieran	Chief Commercial Officer	Nov 10 '25	Sale	7.62	25	190	7,362	Nov 13 04:53 PM
Hutton Scott	President & CEO	Nov 10 '25	Sale	7.62	189	1,440	37,311	Nov 13 04:53 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 10 '25	Sale	7.62	50	381	13,147	Nov 13 04:53 PM
SCHULER JACK W	Director	Sep 19 '25	Buy	7.04	142,045	999,997	1,380,745	Sep 23 09:29 AM
SCHULER JACK W	Director	Sep 17 '25	Buy	6.04	15,317	92,571	1,235,644	Sep 19 10:31 AM
SCHULER JACK W	Director	Sep 18 '25	Buy	6.17	3,056	18,854	1,238,700	Sep 19 10:31 AM
SCHULER JACK W	Director	Aug 29 '25	Buy	0.43	3,488,372	1,500,000	24,406,546	Sep 03 04:42 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Aug 13 '25	Sale	0.42	988	411	250,794	Aug 14 05:25 PM
Hutton Scott	President & CEO	Aug 13 '25	Sale	0.42	3,772	1,570	728,824	Aug 14 05:25 PM
O'Kane Kieran	Chief Commercial Officer	Aug 13 '25	Sale	0.42	476	198	140,065	Aug 14 05:24 PM
Pestano Gary Anthony	Chief Development Officer	Aug 13 '25	Sale	0.42	442	184	157,878	Aug 14 05:24 PM
Vazquez Chris	Chief Accounting Officer	Aug 13 '25	Sale	0.42	228	95	18,375	Aug 14 05:24 PM
SCHULER JACK W	Director	May 16 '25	Buy	0.27	4,000,000	1,070,000	20,194,935	May 20 04:11 PM
SCHULER JACK W	Director	May 19 '25	Buy	0.34	723,239	246,624	20,918,174	May 20 04:11 PM
Vazquez Chris	Chief Accounting Officer	May 12 '25	Sale	0.36	112	40	18,113	May 13 06:36 PM
Vazquez Chris	Chief Accounting Officer	May 13 '25	Sale	0.35	112	40	18,001	May 13 06:36 PM
Pestano Gary Anthony	Chief Development Officer	May 12 '25	Sale	0.36	223	80	157,163	May 13 06:36 PM
Pestano Gary Anthony	Chief Development Officer	May 13 '25	Sale	0.35	222	78	156,941	May 13 06:36 PM
O'Kane Kieran	Chief Commercial Officer	May 12 '25	Sale	0.36	239	86	139,290	May 13 06:35 PM
O'Kane Kieran	Chief Commercial Officer	May 13 '25	Sale	0.35	238	84	139,052	May 13 06:35 PM
Hutton Scott	President & CEO	May 12 '25	Sale	0.36	1,888	679	722,271	May 13 06:35 PM
Hutton Scott	President & CEO	May 13 '25	Sale	0.35	1,887	666	720,384	May 13 06:35 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 12 '25	Sale	0.36	496	178	249,121	May 13 06:35 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 13 '25	Sale	0.35	496	175	248,625	May 13 06:35 PM
Vazquez Chris	Chief Accounting Officer	Feb 11 '25	Sale	0.92	3,630	3,355	17,623	Feb 12 05:12 PM
Pestano Gary Anthony	Chief Development Officer	Feb 11 '25	Sale	0.92	16,748	15,479	156,008	Feb 12 05:12 PM
O'Kane Kieran	Chief Commercial Officer	Feb 11 '25	Sale	0.92	17,527	16,198	128,039	Feb 12 05:11 PM
Hutton Scott	President & CEO	Feb 11 '25	Sale	0.92	83,660	77,319	701,947	Feb 12 05:11 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 11 '25	Sale	0.92	24,664	22,794	246,460	Feb 12 05:11 PM
Hutton Scott	Officer	Feb 11 '25	Proposed Sale	0.95	83,660	79,477		Feb 11 04:41 PM
Cowie Robin Harper	Officer	Feb 11 '25	Proposed Sale	0.95	24,664	23,431		Feb 11 04:41 PM
Pestano Gary Anthony	Officer	Feb 11 '25	Proposed Sale	0.95	16,748	15,911		Feb 11 04:41 PM
O'Kane Kieran	Officer	Feb 11 '25	Proposed Sale	0.95	17,527	16,651		Feb 11 04:40 PM

EVCM

EverCommerce Inc

BDSX

Biodesix Inc

Upgrade your FINVIZ experience